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Abstract
Purpose This study evaluated the impact of limited and
strenuous physical exercise on [
18F]methylcholine uptake
in muscle.
Methods Ten consecutive patients participated, three of
whom had strict bed rest, three were allowed to walk
around and four performed strenuous single arm exercise
by lifting a 7.5-kg weight. [
18F]Methylcholine uptake was
measured in the biceps and gluteus muscles on both sides.
Results Strenuous exercise resulted in a 202% increase in
[
18F]methylcholine uptake in the activated biceps muscle as
well as a 112% increase in muscle groups used to retain
body position. This resulted in asymmetrical images that
were visually less easy to interpret. In walking patients
there was a more limited increase in biceps (45%) and
gluteus (74%) muscle uptake, without visually recognizable
differences.
Conclusion Strenuous exercise may result in a considerable
increase in [
18F]methylcholine uptake in muscle and should
be avoided prior to imaging. Strict bed rest does not seem
to be required. Tracer injection while resting on the scanner
remains a safe approach.
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Introduction
Imaging of choline metabolism with positron emission
tomography (PET), with either [
11C]- or [
18F]-labelled
choline, is increasingly used for detection, staging and
surveillance of malignancies. [
18F]Methylcholine PET
(choline PET) especially performs well in tumour types
where fluorodeoxyglucose (FDG) uptake is generally
limited, such as prostate cancer or differentiated breast
cancer, and where tumour is surrounded by high physio-
logical concentrations of FDG, such as primary brain
tumours, brain metastases or prostate cancer [1–3].
Choline PET is a relatively new technique, and some
uncertainties still exist with respect to the patient prepara-
tion that is needed to achieve an optimal biodistribution of
labelled choline and a good image quality. For FDG PET
there is extensive consensus about the requirements for
patient preparation [4], including the duration of fasting
time and the need for bed rest in order to minimize
physiological uptake of FDG in muscle [5]. The issue of
(bed) rest prior to choline PET scanning is more contro-
versial. Most authors believe that at least [
11C]choline is not
hampered by muscle uptake, and they see no obvious
reasons for bed rest [6]. As a consequence most publica-
tions on choline PET do not report anything about (bed)
rest or the avoidance of strenuous exercise prior to
scanning.
However, most centres currently use [
18F]-labelled
choline due to lack of an on-site cyclotron. [
18F]Methylcho-
line is chemically different from unmethylated choline, and
it has a slightly altered biological behaviour in several
aspects. This is illustrated by the rapid renal excretion of
[
18F]methylcholine, which is absent in [
11C]choline.
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18F]methylcholine in muscle
depends on exercise, and if specific patient preparation is
needed prior to imaging, is currently unknown.
In this study we evaluate the impact of limited and
strenuous exercise on the uptake of [
18F]methylcholine in
muscle, and we derive recommendations for optimal
imaging in clinical practice.
Materials and methods
Ten consecutive patients were enrolled in this study, three
of whom had strict (bed) rest, three were allowed to walk
around and four performed strenuous single arm exercise.
Resting patients were asked to avoid all physical exercise in
the hours prior to imaging and were positioned on the PET/
CT scanner to rest from 5 min prior to administration of the
tracer. Patients who were allowed to walk received no
specific preparation instructions, and they were asked to
walk a distance of about 50 m from the injection room to
the scanner directly after administration of the tracer, after
which the imaging procedure was immediately started. The
arm exercise involved continuous lifting of a 7.5-kg weight
with the dominant arm with the patient sitting in an upright
position, with an intravenous catheter in the other (relaxed)
arm for tracer administration, whereafter the patient walked to
the scanner. Nospecificdietarypreparationswereundertaken.
All patients were referred for choline PET/CT for
restaging of recurrent prostate cancer, as detected by rising
prostate-specific antigen (PSA) in serum after primary
treatment. Patients were scheduled for a routine PET/CT
scan for which they received on average 190 MBq of [
18F]
methylcholine as an intravenous injection. All images were
acquired using an integrated PET/CT scanner with time-of-
flight capabilities (Gemini II, Philips Healthcare, Cleveland,
OH, USA). PETimages were acquired from mid-thigh to the
base of the skull with attenuation correction based on low-
dose CTwithin 5 min after administration of [
18F]methylcho-
line in order to limit renal excretion to the bladder. All
patients were scanned in the prone position with the arms
down to allow evaluation of the biceps muscles.
The generated images (PET, low-dose CT and fused
PET/CT) were displayed using the OsiriX DICOM viewer
in a Unix-based operating system (MAC OS X, Mac Pro,
Apple) and were visually evaluated on the basis of two-
dimensional orthogonal reslicing. The uptake of [
18F]
methylcholine [mean standardized uptake value (SUVmean)]
in muscle was measured in a spacious and representative
cylindrical region of interest with a thickness of 5 slices
(4 mm each) in both biceps muscles and both gluteal
muscles (see Fig. 1). The strict bed rest [
18F]methylcholine
uptake was used as the gold standard to compare with the
limited and strenuous physical exercise for semi-
quantification.
Results
All patients adhered to the preparations as described. The
patients assigned to arm exercise reported it as “very
demanding”, and they all reached the maximum achievable
muscle exercise after 3 min. The PET/CT image quality
was visually adequate in all cases. The results of muscle
uptake quantification are listed in Table 1.
Fig. 1 Muscle uptake quantifi-
cation. Transverse slices of [
18F]
methylcholine PET (right) and
image fusion with low-dose CT
(left), showing the regions of
interest used for evaluation of
muscle uptake (green circles).
Volumes with a thickness of 5
slices were delineated in the
biceps (top) and gluteus maxi-
mus (bottom) muscles on both
sides
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and gluteal muscles (SUVmean varied between 0.57 and
0.98), as well as differences between left and right in the
same muscle group (up to 23%). This indicates that
differences in muscle uptake of [
18F]methylcholine within
and between individual patients is physiological and is
probably unavoidable to some extent.
Walking patients had a higher uptake in all evaluated
muscle groups relative to resting patients, with the average
SUVmean of the biceps rising 45% and the gluteus
increasing 74%. However, this did not result in larger left-
right differences or in visually recognizable differences in
image quality or interpretation.
Strenuous exercise with one arm resulted in a considerable
increase in [
18F]methylcholine uptake in the activated biceps
muscle (Fig. 2), on average with 202% relative to the resting
arm, and with 182% relative to the average biceps muscles
of resting patients. At the same time it was visually apparent
that the uptake of [
18F]methylcholine in muscles elsewhere
in the body increased as well, depending on the muscle
groups that the patient had activated during exercise to retain
the body position and for breathing. As an example, the
Patients Biceps (SUVmean) Gluteus (SUVmean)
Number Age (years) Domin. Left Right Difference Left Right Difference
Resting
1 74 R 0.98 0.84 17% 0.76 0.79 4%
2 77 R 0.70 0.57 23% 0.76 0.75 1%
3 58 R 0.70 0.91 12% 0.64 0.72 11%
Walking
4 50 R 0.86 0.86 0% 0.90 1.04 13%
5 61 R 1.60 1.37 17% 1.63 1.99 18%
6 64 R 1.11 0.99 12% 1.08 1.10 2%
Exercise
7 72 L 2.27 1.10 106% 2.09 1.33 57%
8 60 R 0.72 2.56 256% 1.61 2.28 42%
9 65 R 0.50 1.94 288% 0.43 1.53 256%
10 67 R 0.79 2.03 157% 1.77 1.45 18%
Table 1 [
18F]Methylcholine up-
take in muscle
[
18F]Methylcholine muscle up-
take in resting, walking and exer-
cising patients. Patients in the
exercise group lifted a weight with
their dominant arm
Domin. dominant arm side
Fig. 2 The effect of strenuous arm exercise. Maximum intensity
projections from three representative patients who received [
18F]
methylcholine while already resting on the scanner (a), in a separate
injection room followed by a short walk to the scanner (b) and while
performing strenuous exercise with the right arm (c). Note the
markedly increased uptake in the exercised biceps and the muscles
used to retain body position (arrows) and intercostal muscles used for
breathing
528 Eur J Nucl Med Mol Imaging (2011) 38:526–530gluteal muscles increased on average with 112% relative to
resting patients, and also more than in walking patients.
Discussion
[
18F]Methylcholine PET/CT is rapidly gaining ground as a
diagnostic tool, especially for prostate cancer, although the
exact indications are still a topic of discussion. Good
clinical value has been shown for restaging of biologically
relapsed prostate cancer, including detection of local
recurrence, regional lymph node metastases and distant
metastases [7]. A good summary of valuable applications,
including for brain lesions and hepatocellular carcinoma, is
listed in a review by Mertens et al. [8]. However, the
clinical value of choline PET can only be reproduced when
a proper image quality is achieved. Our study demonstrates
that strenuous muscle exercise can have a detrimental effect
on choline PET imaging.
Littleisknown about choline uptakeinmuscle, eitherfrom
tracer studies using [
11C]- or [
18F]-labelled choline. This
study provides some new insights into the fate of [
18F]
methylcholine in muscle and effects of exercise and resting
on it. However, the current approach is limited by the low
number of patients studied and does not allow for statistical
evaluation. It is our intention just to highlight some
mechanisms relevant for the uptake of [
18F]methylcholine
in (normal) muscle and to derive suggestions for an imaging
protocol that avoids negative impact on image quality.
Strenuous exercise results in a diffuse and considerable
increase of [
18F]methylcholine uptake in the exercised
muscle as well as in postural muscles involved in keeping
the patient in an upright sitting position. This did result in
asymmetrical and more “crowded” or “complicated”
images. While we have no proof that this had any influence
on the interpretation of the images with respect to the
detection of prostate cancer lesions, we do classify the
images as visually suboptimal. Limited exercise (walking)
also resulted in a diffuse increase in uptake, but to a much
lesser extent and with no noticeable influence on visual
interpretation of the images.
The uptake of any tracer depends on tracer delivery
(perfusion) and actual uptake in cells (transporters). These
two processes will be involved in uptake of [
18F]methyl-
choline in muscle as well. Due to the observation that [
18F]
methylcholine has a very fast biodistribution (within a few
minutes), we think that muscle perfusion is an important
mechanism in biodistribution of the tracer. Strenuous
exercise is likely to result in grossly increased muscle
perfusion, whereas limited exercise is not. Also the diffuse
and regional character of the increased [
18F]methylcholine
uptake after exercise agrees with the concept of muscle
perfusion playing a role.
These observations may have an impact that goes
beyond the uptake of [
18F]methylcholine in normal muscle
alone. Local perfusion can also play an important role in
choline uptake in tumour tissue, as has been suggested for
liver hepatocellular carcinoma [9] and certain differentiated
tumours of brain and lung [10, 11], or in infection and
inflammation [12, 13]. These effects may especially be of
interest for imaging of tumours that are located within soft
tissues, such as sarcomas, especially when limited tracer
uptakeisexpectedinthetumour.Toourknowledgeonly[
11C]
choline has been used in PET imaging of musculoskeletal
tumours [14, 15], and its relation to muscle perfusion has not
been clarified. Our data suggest that, when using [
18F]
methylcholine, avoiding physical exercise could be of value
when attempting to image soft tissue sarcomas within muscle
compartments or in comparable situations.
Avoiding muscle exercise is not the only factor that
influences [
18F]methylcholine biodistribution and image
interpretation. When patients are already positioned on the
scanner during tracer administration the scan may be started
more quickly after the injection. In combination with the
absence of gravity in the direction of the bladder, this may
further reduce the amount of tracer in the bladder during
imaging relative to patients who have been walking.
Therefore, tracer administration on the scanner remains a
very good and safe approach. When this is not an option,
we may state that walking a short distance does not result in
serious changes in muscle uptake.
Conclusion
Strenuous exercise may result in a considerable increase in
[
18F]methylcholine uptake in muscle, most likely due to
increased local perfusion, and should be avoided shortly
prior to imaging. However, this effect seems to be
negligible when only walking a short distance, and thus
strict bed rest seems not to be required during or after
administration of [
18F]methylcholine. Tracer injection while
resting on the scanner remains a very safe approach.
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